ArticlePlant biotechnology journal2025
A plant viral effector subverts FER-RALF1 module-mediated intracellular immunity.
Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Molecular Mechanisms of Programmed Cell Death During Somatic Embryo Detachment from Callus in Indirect Somatic Embryogenesis.International journal of molecular sciences · 2026Review
- Decoding MAPK cascades in plant immunity: Activation, regulation, integration, and pathogen manipulation.Journal of integrative plant biology · 2026Review
- A RALF22-like Peptide Coordinates Salt Tolerance and Disease Susceptibility in Poplar (Plants (Basel, Switzerland) · 2026Article
- Peptide signaling at the intersection of growth, nutrient sensing, and stress responses.The Plant journal : for cell and molecular biology · 2026Review
- Silencing Host Factors with Hairpin RNA for Virus Resistance.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Identification of the tetraspanin gene family in sugarcane and its response to sugarcane mosaic virus infection.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The receptor-like kinase FERONIA (FER) is a prominent member of the Catharanthus roseus RLK1 (CrRLK1L) family, functioning as a modulator of immune receptor kinase complex formation in response to rapid alkalinization factors (RALFs). Typically, FER recognizes mature extracellular RALFs to combat bacterial and fungal infections. However, any role of the FER-RALF signalling cascade in plant viral infections remains unexplored. Here, we used turnip mosaic virus (TuMV), an important member of the genus Potyvirus, and the host Nicotiana benthamiana as a model system to explore the role of the FER-RALF cascade in plant-virus interactions. RALF1 from N. benthamiana (NbRALF1) positively regulated host resistance to inhibit TuMV infection. Co-expression studies showed that this process does not involve the conserved RRXL and YISY motifs typically associated with RALF function. Instead, NbRALF1 induced cell death and significantly inhibited TuMV infection in a manner that depends on the entire RALF1 sequence and also NbFER. These results suggest a novel mechanism where NbRALF1 may inhibit viral infection through intracellular interactions with NbFER, differing from the previously reported extracellular FER-RALF interactions that induce resistance to fungi and bacteria. Furthermore, we discovered that TuMV 6K2 interacts with NbRALF1 and promotes its degradation through the 26S proteasome pathway, thereby counteracting the host resistance induced by the NbFER-NbRALF1 cascade. Our findings imply the existence of an uncharacterized intracellular immunity signalling pathway mediated by the NbFER-NbRALF1 cascade and reveal a mechanism by which plant viruses counteract RALF1-FER module-mediated immunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.